4511 - 4520 of 9104 Results
Title
Year
- Facial Analysis Software Helps Screen for Parkinson's Disease2022RESTRICTEDTitle: Facial Analysis Software Helps Screen for Parkinson's DiseaseJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000817640.88538.ffCitation Count: 0
-
OPENTitle: “Stretched Slinky” SignJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 12Issue #: 5Start Page: e121End Page: e123Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000200075Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9647796Citation Count: 3
- Can Legislation Save the Day for Challenges Related to Prior Authorization?2022RESTRICTEDTitle: Can Legislation Save the Day for Challenges Related to Prior Authorization?Journal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000817608.36002.47Citation Count: 2
- Home Wireless Device Tracks Body Movements in People with Parkinson's Disease2022RESTRICTEDTitle: Home Wireless Device Tracks Body Movements in People with Parkinson's DiseaseJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 22Issue #: 21Start Page: 6End Page: 7Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000899540.26889.fcCitation Count: 1
-
OPENTitle: The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor EncephalitisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903316.50895.83Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S39.full.pdfCitation Count: 4
- Understanding Correlation of Electroclinical Findings With Functional and Neuropsychiatric Outcomes in Patients with LGI1-Encephalitis2022RESTRICTEDTitle: Understanding Correlation of Electroclinical Findings With Functional and Neuropsychiatric Outcomes in Patients with LGI1-EncephalitisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903424.19914.85Citation Count: 0
- Drug News2022RESTRICTEDTitle: Drug NewsJournal Name: NursingPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 52Issue #: 1Start Page: 8End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nurse.0000803500.30920.0cCitation Count: 0
- Editorial introductions2022RESTRICTEDTitle: Editorial introductionsJournal Name: Current Opinion in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 35Issue #: 1Start Page: viiEnd Page: ixPublication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wco.0000000000001027Citation Count: 1
- Issue Overview2022RESTRICTEDTitle: Issue OverviewJournal Name: ContinuumPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.con.0000840008.09408.75Citation Count: 0
- 2022 Emerging Science Abstracts2022RESTRICTEDTitle: 2022 Emerging Science AbstractsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000200917Citation Count: 1